{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:59:07Z","timestamp":1773655147622,"version":"3.50.1"},"reference-count":5,"publisher":"Australian Centre for Disease Control","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Commun Dis Intell"],"DOI":"10.33321\/cdi.2019.43.27","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:11:31Z","timestamp":1560730291000},"source":"Crossref","is-referenced-by-count":0,"title":["Australian Gonococcal Surveillance Programme, 1 January to 31 March 2018"],"prefix":"10.33321","volume":"43","author":[{"given":"Monica M","family":"Lahra","sequence":"first","affiliation":[{"name":"The World Health Organisation Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Prince of Wales Hospital, Randwick, NSW, 2031 for The National Neisseria Network, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney P","family":"Enriquez","sequence":"additional","affiliation":[{"name":"The World Health Organisation Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Prince of Wales Hospital, Randwick, NSW, 2031 for The National Neisseria Network, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18788","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Whiley DM, Jennison A, Pearson J, Lahra MM. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. Lancet Infect Dis. 2018;18(7):717\u20138.","DOI":"10.1016\/s1473-3099(18)30340-2"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. Rapid Risk Assessment: Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia. 2018. Available online: https:\/\/ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-extensively-drug-resistant-xdr-neisseria-gonorrhoeae-united","DOI":"10.5005\/jp\/books\/12516_24"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Lahra MM, Enriquez RP. Australian Gonococcal Surveillance Programme Annual Report, 2016. Commun Dis Intell (2018). 2018;42. pii: S2209-6051(18)00013-1.","DOI":"10.33321\/cdi.2019.43.13"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Lahra MM, Ward A, Trembizki E, Hermanson J, Clements E, Lawrence A, et al. Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia. Lancet Infect Dis. 2017;17(2):133\u20134.","DOI":"10.1016\/s1473-3099(17)30007-5"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Unemo M. Current and future antimicrobial treatment of gonorrhoea\u2013the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364.","DOI":"10.1186\/s12879-015-1029-2"}],"container-title":["Communicable Diseases Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/75F30C0D2C126CAECA2583940015EDE3\/$File\/australian_gonococcal_surveillance_programme__1_january_to_31_march_2018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:35:04Z","timestamp":1749580504000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/view\/624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":5,"URL":"https:\/\/doi.org\/10.33321\/cdi.2019.43.27","archive":["Portico","Portico","Portico"],"relation":{},"ISSN":["2209-6051"],"issn-type":[{"value":"2209-6051","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]}}}